Entrada Beats on Q3 Loss Per Share but Revenue Collapses 44% to $905K
TRDA is trading near its 52-week low of $4.109 (12% above the low).
Summary
Entrada posted a Q3 adjusted loss of $0.94 per share, better than the $1.01 consensus loss, but revenue fell 43.9% to $905 thousand against roughly $5.87 million expected — a wide miss on the top line. The quarterly net loss was $39.74 million. The company ended the period with $193.0 million in cash, which it says funds operations into Q4 2027, though the 10-Q carries a going-concern disclosure. This follows the positive ELEVATE-45-201 Cohort 1 topline data reported October 14, so the revenue shortfall is the number that matters here rather than the pipeline readout. Shares are down 50.8% year to date and closed at $5.06 ahead of the report.
At the time of this announcement, TRDA was trading at $4.59 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $178.7M. The 52-week trading range was $4.11 to $16.45. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.